Q4 2025
Read transcript →Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$24.60
-1.40%
Mkt Cap $2.47B
Q1 2025
Read transcript →Q3 2024
Read transcript →Q1 2024
Read transcript →Q4 2023
Read transcript →Q3 2023
Read transcript →Q2 2021
Read transcript →